Home › Funds › Eversept Partners, LP › BMRN

Eversept Partners, LP position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

Eversept Partners, LP reported holding 249,607 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$14.3M, representing 0.75% of its reported portfolio and ranking #35 among its reported holdings. Eversept Partners, LP has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)249.61K sh
Reported value held$14.28M
Portfolio Weight0.75%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's BMRN position evolved

Eversept Partners, LP first disclosed a stake in BMRN in Q3 2025 at 146,642 shares (US$7.9M). The position peaked in Q2 2026 at 249,607 shares, worth US$14.3M. Across 4 filings, Eversept Partners, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 249,607 shares valued at US$14.3M — an increase of 41,839 shares quarter over quarter.. Notable position changes include a 36% trim in Q4 2025 (shares fell 5% over the following quarter), a 122% increase in Q1 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 146.64K $7.94M New
Q4 2025 93.75K $5.57M Reduce
Q1 2026 207.77K $11.74M Add
Q2 2026 249.61K $14.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 27 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$812.0M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has Eversept Partners, LP held BMRN?

Eversept Partners, LP has disclosed BMRN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Eversept Partners, LP's current position in BMRN?

As of Q2 2026, Eversept Partners, LP holds 249.61K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $14.28M, representing 0.75% of its reported portfolio and ranking #35.

Has Eversept Partners, LP been buying or selling BMRN?

In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in BMRN. The position peaked in Q2 2026 at 249.61K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.